Adel Rezaei-Moghadam, Daryoush Mohajeri, Behnam Rafiei, Rana Dizaji, Asghar Azhdari, Mahdi Yeganehzad, Maryamossadat Shahidi, Mohammad Mazani*
|
Majid Mohammad-Shahi, Masoud Veissi, Fatemeh Haidari, Hajieh Shahbazian, Gholam-Abas Kaydani, Fatemeh Mohammadi*
|
Khalil Ansarin, Maryam Khoubnasabjafari, Abolghasem Jouyban*
|
Abolghasem Jouyban*, Djavanshir Djozan, Parastou Mohammadandashti, Aliakbar Alizadeh-Nabil, Hooshangh Ghorbanpour, Maryam Khoubnasabjafari, Mohammad Mohammadzadeh
|
Sepideh Zununi Vahed, Mohammadreza Nakhjavani, Jalal Etemadi, Henghame Jamshidi, Nima Jadidian, Tala Pourlak, Sima Abediazar*
|
Shiva Kalantari, Mohammad Naji, Mohsen Nafar* , Hootan Yazdani-Kachooei, Nasrin Borumandnia, Mahmoud Parvin
Two pathways were analyzed for the pathogenesis of FSGS disease using RT-PCR. Correlation of the target genes with pathological characteristics of the FSGS was studied. The implication of these target genes and pathways in the pathogenesis of FSGS was found.
|
Nurul Azmir Amir Hashim , Sharaniza Ab-Rahim, Wan Zurinah Wan Ngah, Sheila Nathan, Nurul Syakima Ab Mutalib, Ismail Sagap, A. Rahman A. Jamal, Musalmah Mazlan*
Global Serum from metabolomics on colorectal cancer (CRC) identified 11 differential metabolites which able to identify a new set of sample with 80% of accuracy. Pathway analysis shows purine, catecholamine and amino acid metabolism were altered in CRC patients.
|